Havrdova E, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Relapsing Multiple Sclerosis in the OPERA I and OPERA II Trials. EAN 2017, PR1092.
D2 CAR T-cellen bij gerecidiveerd of refractair hoogrisico neuroblastoom
jun 2023 | Neuro-oncologie